What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Elder's Force Index

Score

0.75

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 36 8.6 0.64% 1.21% 4.2% -2.2% 52.9%
SHORT 37 13.0 0.59% 1.05% 7.4% -8.2% -9.1%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

ELDERS FORCE INDEX


Last Signal:

BEARISH


Trading: SELL @ $2.95
Signal Strength: MEDIUM
Recommendation:

Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.


Opthea (ASX:OPT) current price has highlighted recent selling pressure. Currently, the Elders Force Index is -7528.



Elders Force Index (EFI) measures the power behind a price movement using price and volume. The indicator can also be used to identify potential reversals and price corrections. The EFI is an oscillator that fluctuates between positive and negative values above and below a Zero Line.

Calculation: Elders Force Index (EFI):
1) Close – Close yesterday x Volume;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Elder's Force Index

Download
Company Close Change(%) Volume Value Signal
MCY Mighty River Power 5 7.1 7,917 -92 BEARISH
RCT Reef Casino 2.62 6.9 38,587 -828 BEARISH
HSN Hansen Technologies 3.54 4.4 1,363,425 -59,939 BEARISH
CAR Carsales 16.74 4 912,376 -92,167 BEARISH
BPT Beach Petroleum 2.49 3.8 6,575,446 -477,446 BEARISH
GTN GTN Resources 0.7 3.7 7,121 -3,080 BEARISH
PNR Pacific Niugini Minerals 0.14 3.7 2,478,287 -514 BEARISH
LOV Lovisa 12.02 3.4 137,948 -21,691 BEARISH
BLX Beacon Lighting 1.23 3.4 22,040 -1,190 BEARISH
WSA Western Areas 2.79 3.3 3,344,659 -458,024 BEARISH